anthonyyazdaniml/gliner-biomed-curated-corpus huggingface dataset:
(1) Background: Functional habitual constipation (FC) in children is a common gastrointestinal problem. This study aimed to explore the local community's view on this problem, emphasising the challenges that parents face in managing the condition and its impact on the child's quality of life. (2) Methods: A prospective, cross-sectional, community-based study was conducted between March and July 2023. The survey received 933 responses. The target population was adults over 18 years of age living in the Eastern Province of Saudi Arabia. An electronically distributed questionnaire was designed in the Arabic language. (3) Results: The mean knowledge scores were significantly higher in females than males, with t (931) = -2.701 and p = 0.007. The Bonferroni post hoc test results indicated that participants between 20 and 29 years exhibited significantly higher levels of knowledge scores compared to those between 30 and 39 years. Furthermore, the results revealed that those with three or more children had significantly higher knowledge scores compared to those with only one child. (4) Conclusions: This study demonstrated that parents in the local community have a good perceived knowledge of FC, but it needs to be linked with practice. They tended to report high levels of perception and demonstrated better practices. These results emphasise the importance of exploring the local community's view on constipation among children.
NSAIDs, including ibuprofen, which is a component of DUEXIS tablets, can cause serious skin adverse reactions such as exfoliative dermatitis, Stevens-Johnson Syndrome (SJS), and toxic epidermal necrolysis (TEN), which can be fatal. NSAIDs can also cause fixed drug eruption (FDE). FDE may present as a more severe variant known as generalized bullous fixed drug eruption (GBFDE), which can be life-threatening. These serious events may occur without warning. Inform patients about the signs and symptoms of serious skin reactions and to discontinue the use of DUEXIS at the first appearance of skin rash or any other sign of hypersensitivity. DUEXIS is contraindicated in patients with previous serious skin reactions to NSAIDs [see Contraindications (4)].
530,902. Phosphoric acid derivatives of aminobenzenesulphonamide salts. HOFFMANN-LA ROCHE & CO., AKT.-GES., F. July 5, 1939, No. 19577. Convention date, July 29, 1938. [Class 2 (iii)] Compounds having a bactericidal action are prepared by neutralizing phosphoric acid derivatives of 4-amino-benzene sulphonamides with bases which contain at least four carbon atoms and one nitrogen atom and have at least one ring present, the nitrogen atom being either a constituent of a ring or in aliphatic combination or by reacting salts of phosphoric acid derivatives of 4-amino-benzene sulphonamides with salts of such bases. Bases mentioned include quinine, acriflavine or other quinoline and acridine bases. In examples: (1) An aqueous solution of quinine monohydrochloride is reacted with an aqueous solution of the sodium salt of sulphanilamide phosphamic acid to give the quinine salt of sulphanilamide phosphamic acid. (2) The same compound as obtained in example (1) is also obtained by treating an aqueous suspension of quinine with sulphanilamide phosphamic acid. (3) Moist hydroquinine base is neutralized with an aqueous solution of sulphanilamide phosphamic acid. (4) Tyramine hydrochloride and the sodium salt of sulphanilamide phosphamic acid are reacted in aqueous solution to effect salt formation. (5) Emetine base is reacted in an aqueous medium with sulphanilamide phosphamic acid to give the corresponding salt. (6) Hordenine sulphate and sulphanilamide phosphamic acid are reacted together to form the sulphanilamide phosphamate of hordenine.
A monitoring system comprises a module having at least one sensor and preferably skin and ambient temperature sensors within a housing. The device may be durable or disposable. The housing may be provided with certain surface features and shapes to facilitate mounting on and interface with the skin of the wearer for more accurate temperature measurement. A receiver may be provided to obtain and display data from the module. The module may also display the output data. The output data comprises both detected and derived data relating to physiological and contextual parameters of the wearer and may be transmitted directly to a local recipient or remotely over a communications network. The system is capable of deriving and predicting the occurrence of a number of physiological and conditional states and events and reporting the same as output data.
The intravenous combined nebulization patient group was divided into two subgroups based on the different doses received -25mg q12h and 50mg q12h. Patients in the intravenous combination nebulized polymyxin B group received a total medication dose of 1.25 to 1.5mg/kg, of which 25-50mg was used for nebulization and the remaining portion was used for intravenous administration. The specific method of nebulization is to receive nebulized bronchodilator 30 minutes before nebulization, add 25-50mg of polymyxin B to 5ml of physiological saline for dilution, use a vibrating mesh nebulizer to connect to the patient's ventilator pipeline suction tube, do not change the original ventilator parameter settings, and continue nebulization for 30 minutes. After 30 minutes, regardless of whether there is any residue of the nebulized drug, it will be discarded according to general nursing methods.
Infusion-related reactions (IRRs) have been observed in patients treated with ONPATTRO. In clinical studies, all patients received premedication with a corticosteroid, acetaminophen, and antihistamines (H1 and H2 blockers) to reduce the risk of IRRs. In a controlled clinical study, 19% of ONPATTRO-treated patients experienced IRRs, compared to 9% of placebo-treated patients. Among ONPATTRO-treated patients who experienced an IRR, 79% experienced the first IRR within the first 2 infusions. The frequency of IRRs decreased over time. IRRs led to infusion interruption in 5% of patients. IRRs resulted in permanent discontinuation of ONPATTRO in less than 1% of patients in clinical studies. Across clinical studies, the most common symptoms (reported in greater than 2% of patients) of IRRs with ONPATTRO were flushing, back pain, nausea, abdominal pain, dyspnea, and headache [see Adverse Reactions (6.1)]. Severe hypotension and syncope have been reported as symptoms of IRRs in the expanded access program and postmarketing setting.

Patients should receive premedications on the day of ONPATTRO infusion, at least 60 minutes prior to the start of infusion [see Dosage and Administration (2.2)]. Monitor patients during the infusion for signs and symptoms of IRRs. If an IRR occurs, consider slowing or interrupting the ONPATTRO infusion and instituting medical management (e.g., corticosteroids or other symptomatic treatment), as clinically indicated. If the infusion is interrupted, consider resuming at a slower infusion rate only if symptoms have resolved. In the case of a serious or life-threatening IRR, the infusion should be discontinued and not resumed.

Some patients who experience IRRs may benefit from a slower infusion rate or additional or higher doses of one or more of the premedications with subsequent infusions to reduce the risk of IRRs [see Dosage and Administration (2.2)].
PURPOSE: To gather evidence on the effectiveness and safety of qigong, tai chi, and yoga to modulate symptoms associated with chronic respiratory diseases.
METHODS: A search of systematic reviews was conducted in CINHAL, Embase, PubMed, PsycINFO, SPORTDiscus, and the Cochrane Library from inception to November 2022. Systematic reviews with meta-analyses investigating physical and psychological measures were eligible. The methodological quality of systematic reviews (AMSTAR-2), the spin of information in abstracts, and the overlap of primary studies were explored.
RESULTS: Twenty-seven systematic reviews involving 37 000 participants, 146 studies, and 150 meta-analyses were included. Reviews investigated asthma (n = 4) and chronic obstructive pulmonary disease (COPD) (n = 23). Most reviews discussed their findings without considering the risk of bias of primary studies. The overlap ranged between slight (5%) and very high (35%). Yoga was better than control interventions to improve symptoms related with asthma. In adults with COPD, qigong improved dyspnoea, exercise endurance, lung function, and quality of life, while tai chi and yoga increased exercise endurance.
CONCLUSIONS: The impact of yoga on symptoms associated with asthma varied depending on the lung function parameter and the control group. Qigong, tai chi, and yoga could be effective to improve COPD-related symptoms, especially exercise endurance.
The puncture point was located 3cm outside the corners of the mouth of the affected side, using the Hartel technique. Under CT guidance, the trocar then was inserted through the ipsilateral foramen ovale to the Gasserian ganglion. After accurately puncturing the foramen ovalis, remove the cannula needle core and connected with RF electrode (PMK-21-100, Baylis, Canada) and the RF generator. Electrical stimulation was carried out at 50 Hz to determine the sensory threshold and at 2 Hz to determine the motor threshold. The RF generator was set to the manual PRF mode with a standard setting of 42°C, the UP knob was turned to increase the output voltage until the maximum voltage (bearable without causing pain in conscious patients)was reached; 120 s, 2 times. After removing the RF electrode in the combined treatment group, 2 ml of LP-PRP mixture was injected slowly into the Gasserian ganglion and mandibular nerve.
Waitlist intervention requires participants to wait 6 weeks. This waitlist group will receive the intervention after this 6 week waiting period, due to the exploratory nature of this Pilot Randomized Controlled Trial (RCT).
In this condition, participants will attend a 1-hour virtual ACT psychoeducational workshop where they will learn about ACT, practice the dropping anchor exercise (with a guided image sequence), and learn how to use the ACTaide mobile app, which they will be asked to use to practice the dropping anchor exercise daily for two weeks. The main feature of the ACTaide app is the annotated image sequence to guide users through the steps of the exercise. The app also features customizable reminders notifications. Participants will receive three reminders per day encouraging them to practice the exercise.
This study has designed implemented and evaluated an intervention to promote parental competence and healthy practices in families with children aged 2 to 5 years old, addressing parental self-efficacy an skills. This research followed the first three stages of the Medical Research Council framework for complex interventions: the theoretical, modeling and exploratory trial phases. A randomized control trial with parents of children better 2 to 5 years old was conducted. The program consisted of two hour long four sessions. Parents were grouped in small groups (7-8 participants) and guided by a facilitator whose role was to provide a participative and trusting atmosphere to share opinions and experience in healthy lifestyles and parenting. Data collection was performed at three time points (pre-intervention, post-intervention and follow-up) to asses the preliminary efficacy, acceptability and feasibility of the program.
Compositions for ocular administration contg. (I) colostrum lactoserum, and (II) 0.05-0.2% of vitamin A, its precursors, or its derivatives, are new.  The lactoserum is usually diluted with physiological serum to a concn. of 10g total protein per litre. The compsns. may be in the form of eye drops, creams or gels and may also contain an  antiseptic preservative such as sorbic acid. USE - Treatment of ocular dryness of any cause, the composition having a nutritive and regenerative action.  Also useful in the treatment of corneal ulcers.
For this study, 290 teen and parent/guardian dyads will be randomized into one of three study groups for 12 months with 6 months of active data collection. Teens will be aged 16-17 who committed a moving-related traffic violation and their parent/legal guardian who is most involved with their driving. Dyads will be recruited from both urban and rural counties in Ohio following the teen's moving violation conviction. The study will determine the effectiveness and cost-effectiveness of the intervention on teens' risky driving events, unsafe driving behaviors, traffic violation recidivism, and motor vehicle collisions (MVCs), as well as frequency and quality of parent-teen communications about safe driving practices. Additionally, the study will determine the effectiveness and cost-effectiveness of the peer-delivered intervention vs. expert-delivered intervention on the outcomes of the interest. Finally, the study will assess the barriers/facilitators to the adoption and implementation of the intervention in rural and urban families.
PURPOSE: To provide the oral compsn. which has both of improved anti-calculus and anti-plaque effects but does not stimulate the mucous membrane of the mouth. CONSTITUTION: This compns. contains the polymer of formula I [A is a random polymer residue contg. at least one unit of formula II and at least one unit of formula III ((m), (n) are integers sufficient for providing polymers having a weight average mol.wt. in a range of 400 to 5000; R1 to R4 are H, methyl, ethyl); B is H, residue A; R is OX; X is H, an alkali metal, an alkaline earth metal, a transition metal, ammonium, an alkylamine, an alkanolammonium] and (B) an antimicrobial agent selected from diphenyl ether, bis-guanide, a halogenated carbanilide and salicylamide.  The unit of the formula II is formed of (meth)acrylic acid, an α-substd. acrylic acid, a β-carboxylalkylacrylic acid and the unit of the formula III is formed of maleic acid, fumaric acid, mesaconic acid, citraconic acid and is particularly preferably the polymer formed of the combination of acrylic acid, maleic anhydride and sodium hypophosphite.
BACKGROUND: Targeting the tumor microenvironment represents an emerging therapeutic strategy for cancer. Macrophages are an essential part of the tumor microenvironment. Macrophage polarization is modulated by mitochondrial metabolism, including oxidative phosphorylation (OXPHOS), the tricarboxylic acid (TCA) cycle, and reactive oxygen species content. Isocitrate dehydrogenase 2 (IDH2), an enzyme involved in the TCA cycle, reportedly promotes cancer progression. However, the mechanisms through which IDH2 influences macrophage polarization and modulates tumor growth remain unknown.
METHODS: In this study, IDH2-deficient knockout (KO) mice and primary cultured bone marrow-derived macrophages (BMDMs) were used. Both in vivo subcutaneous tumor experiments and in vitro co-culture experiments were performed, and samples were collected for analysis. Western blotting, RNA quantitative analysis, immunohistochemistry, and flow cytometry were employed to confirm changes in mitochondrial function and the resulting polarization of macrophages exposed to the tumor microenvironment. To analyze the effect on tumor cells, subcutaneous tumor size was measured, and growth and metastasis markers were identified.
RESULTS: IDH2-deficient macrophages co-cultured with cancer cells were found to possess increased mitochondrial dysfunction and fission than wild-type BMDM. Additionally, the levels of M2-associated markers decreased, whereas M1-associated factor levels increased in IDH2-deficient macrophages. IDH2-deficient macrophages were predominantly M1. Tumor sizes in the IDH2-deficient mouse group were significantly smaller than in the wild-type mouse group. IDH2 deficiency in macrophages was associated with inhibited tumor growth and epithelial-mesenchymal transition.
CONCLUSIONS: Our findings suggest that IDH2 deficiency inhibits M2 macrophage polarization and suppresses tumorigenesis. This study underlines the potential contribution of IDH2 expression in macrophages and tumor microenvironment remodeling, which could be useful in clinical cancer research.
INTRODUCTION: Postmenopausal osteoporosis and fractures are widely prevalent. However, the relationship of body composition with bone health in this population remains unclear. The aim of this study was to investigate the association of body composition with bone mineral density (BMD) and 10-year probability of hip fracture in postmenopausal women.
MATERIALS AND METHODS: This is a cross-sectional study. A total of 1285 subjects were included in our study. Body composition and BMD were assessed using dual-energy X-ray densitometry. The 10-year probability of hip fracture of participants was calculated. All participants were categorized into four groups: sarcopenic-obese (SO) group, sarcopenic-nonobese (S) group, nonsarcopenic-obese (O) group, or nonsarcopenic-nonobese control (C) group. Multivariate analyses and binary logistic regression were conducted to explore the relationship of body composition with BMD and 10-year probability of hip fracture.
RESULTS: Participants in S group were 2.8, 4.7 and 4.8 times more likely to develop osteoporosis in the lumbar spine, the total hip and femoral neck sites, respectively. Lean mass was positively correlated with BMD, wherein lumbar spine BMD was significantly affected by appendicular lean mass, while total hip BMD and femoral neck BMD were mainly influenced by trunk lean mass. Total fat mass was positively associated with total hip and femoral neck BMD, but not with lumbar spine BMD. A significant correlation was observed between lean mass and 10-year probability of hip fracture.
CONCLUSION: Changes in body composition in postmenopausal women could affect bone health. A decrease in regional lean mass may be associated with an increased risk of osteoporosis and fractures.
Shampoo containing sodium shale oil sulponate 1% will be used to wash the participants' hair every second day, starting from day 1 to day 15. Each participant in the experimental group will wash their hair with 25ml of the sodium shale oil sulponate 1% shampoo per hair washing session.
The invention discloses a composite covalent hydrogel capable of being released according to requirements and a preparation method and application thereof. The hydrogel is based on cationic polymer and nano silver particles for synergistic sterilization. The nano silver particles are synthesized by taking cationic polymers as templates and then covalently cross-linked with oxidized polysaccharide polymers through acid-sensitive Schiff base bonds, and the Schiff base bonds are broken under an acidic environment generated by bacterial infection, so that gel is degraded to release the cationic polymers, and the cationic polymers are oxidized to generate silver ions for sterilization. The invention also discloses the in vitro and in vivo antibacterial application of the composite covalent hydrogel. The preparation method is simple and low in cost, and the cationic polymer and the nano-silver are combined to prepare the composite hydrogel. The prepared gel can improve the antibacterial effect of single cation polymer gel, can expand the antibacterial spectrum of the nano-silver gel, reduce the toxic and side effects of the nano-silver and realize the synergistic effect of the two. The antibacterial effect of the hydrogel is superior to that of various commercial antibacterial gels on the market.
FIELD: heterocyclic compounds. SUBSTANCE: cephalosporin C is prepared by its adsorption from native solution on the nonionogenic sorbent following its desorption of cephalosporin C from sorbent with aqueous-organic solvent. Then cephalosporin C is desorbed from eluate on the anionic-exchange resin - cross-linked copolymer of N-aminoethylacrylamide and divinyl ester of ethylene glycol of the general formulawhere K - NH-CH-C(O)- ;; M -; R - (CH); ratio m:n = 1:(13.3-32.3); mol. mass is (1-100) x 10. Precipitation is carried out with zinc salt from cephalosporin C solution prepared immediately at cephalosporin C desorption from anionite with aqueous solution of electrolyte. Yield of cephalosporine C is increased from 69 to 72-75%, mass part of impurities is decreased from 15.4 to 3.8, consumption of organic solvent is decreased by 2-fold. EFFECT: improved method of cephalosporin C preparing. 1 tbl
DNA-binding protein-A (DbpA; gene: Ybx3) belongs to the cold shock protein family with known functions in cell cycling, transcription, translation, and tight junction communication. In chronic nephritis, DbpA is upregulated. However, its activities in acute injury models, such as kidney ischemia/reperfusion injury (IRI), are unclear. To study this, mice harboring Ybx3+/+, Ybx3+/- or the Ybx3-/- genotype were characterized over 24 months and following experimental kidney IRI. Mitochondrial function, number and integrity were analyzed by mitochondrial stress tests, MitoTracker staining and electron microscopy. Western Blot, immunohistochemistry and flow cytometry were performed to quantify tubular cell damage and immune cell infiltration. DbpA was found to be dispensable for kidney development and tissue homeostasis under healthy conditions. Furthermore, endogenous DbpA protein localizes within mitochondria in primary tubular epithelial cells. Genetic deletion of Ybx3 elevates the mitochondrial membrane potential, lipid uptake and metabolism, oxygen consumption rates and glycolytic activities of tubular epithelial cells. Ybx3-/- mice demonstrated protection from IRI with less immune cell infiltration, endoplasmic reticulum stress and tubular cell damage. A presumed protective mechanism was identified via upregulated antioxidant activities and reduced ferroptosis, when Ybx3 was deleted. Thus, our studies reveal DbpA acts as a mitochondrial protein with profound adverse effects on cell metabolism and highlights a protective effect against IRI when Ybx3 is genetically deleted. Hence, preemptive DbpA targeting in situations with expected IRI, such as kidney transplantation or cardiac surgery, may preserve post-procedure kidney function.
Participants will be provided an online interactive platform to access electronic modules (total of 10) on: IBS-related pain neurophysiology and the brain-gut axis and self-management strategies. There is no additional intervention.
Cryptosporidiosis, primarily caused by Cryptosporidium parvum, is a significant cause of diarrhea in pre-weaned dairy calves. To investigate the prevalence of Cryptosporidium among pre-weaned diarrheic dairy calves and identify potential sources of infection in northern China, 234 fecal samples from 18 farms in six regions were analyzed for Cryptosporidium. Furthermore, 217 bedding samples from both occupied and unoccupied calf hutches, heating lamp pens, and individual calving pens in eight farms in Beijing were also examined for the presence of the parasite. All samples were screened for Cryptosporidium spp. using nested PCR targeting the SSU rRNA gene fragment, and C. parvum was subtyped with nested PCR targeting the 60 kDa glycoprotein gene. The prevalence of Cryptosporidium was 33.3%, with C. parvum and C. bovis constituting 29.9% and 3.4% of cases, respectively. The positive rate of Cryptosporidium in 1- to 4-week-old calves ranged from 9.6 to 63.6%. Analysis of the gp60 fragment of C. parvum revealed four subtypes: IIdA15G1, IIdA17G1, IIdA19G1, and IIdA20G1. Besides the bedding samples in heating lamp pens, both C. parvum and C. bovis were detected in bedding samples throughout the other regions. A significant positive correlation between the detection rate of Cryptosporidium in fecal samples and that in the bedding materials of occupied calf hutches (R = 0.93, P = 0.002). These findings suggest that C. parvum is the predominant species among pre-weaned diarrheic dairy calves in northern China. Contaminated bedding materials may act as sources of infection for newborn calves.